Coronavirus

Direct-to-consumer COVID-19 testing

Concerns over direct-to-consumer COVID-19 tests may override the benefits, with issues of safety, efficacy, and ethics in question.

From Penn LDI



In the News


The New York Times

Why you shouldn’t worry about studies showing waning coronavirus antibodies

Scott Hensley of the Perelman School of Medicine said it’s normal for antibody levels to drop after the body clears an infection. “It doesn’t mean that those people no longer have antibodies. It doesn’t mean that they don’t have protection,” he said.

FULL STORY →



Philadelphia Inquirer

America can overcome COVID-19, despite Trump’s do-nothing approach. Here’s how

PIK Professor Ezekiel Emanuel spoke about the Trump administration’s response to the pandemic and offered advice to a possible Biden administration. “There must be a management strategy, with the locus in the White House,” said Emanuel.

FULL STORY →



NBC News

Women who inspire: Culturists breaking through during COVID-19

Alison Buttenheim of the School of Nursing helped found “Dear Pandemic,” a project that recruits doctoral-degree-holding women to answer complex questions about the coronavirus on Facebook, Twitter, and Instagram.

FULL STORY →



Business Insider

A Chinese city says it tested 3 million people for COVID-19 in 2 days, showing how much the U.S. and Europe still lag behind in testing capability

Carolyn Cannuscio of the Perelman School of Medicine commented on the U.S. ability to test for COVID-19. “We have a broken testing system, and that sets us up for failure in contact tracing because people are waiting so long to get their test results that we have missed a critical period for counseling those people to stay home and avoid infecting others,” she said.

FULL STORY →



The Hill

Advocates plead for housing aid as eviction cliff looms

Michael Levy of the Perelman School of Medicine spoke about the dangers posed by evictions during a pandemic. “Larger households are dangerous for infectious disease because you have more people so there's more avenues of ingress of the virus,” he said. “The worry was even a fairly modest change in the household size structure in a population could have kind of an outsized effect on an epidemic on a city scale.”

FULL STORY →



The New York Times

Can Trump really speed approval of COVID treatments?

Susan Ellenberg of the Perelman School of Medicine said she’d want to see clinical trial data before deciding whether to trust a coronavirus vaccine that was approved under Emergency Use Authorization. “If it looked to me like it was very effective, and I didn’t see any safety problems, then definitely,” she said. “I think I would recommend people getting it. I would get it myself.”

FULL STORY →